AIHTA - Publications - Search - Triphasic biomaterial for augmentation of the osteoporotic femoral neck

Kheder, M. and Vandepeer, M. and Forel, D. and Tivey, D. (2021): Triphasic biomaterial for augmentation of the osteoporotic femoral neck. Decision Support Document 126.

[thumbnail of DSD_126.pdf]
PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader

OSSURE® Local Osteo-Enhancement Procedure (LOEP®) is a minimally invasive surgical procedure. It involves the injection of a calcium-based biomaterial (AGN1) into an area of osteoporotic bone loss, where –according to the manufacturer- it reportedly provides immediate strength. The intended outcome is increased bone strength and preventing fragility fractures. AGN1 LOEP is a once-off minimally invasive surgical treatment that aims to resorb and replace the implant material with new bone. AGN1 LOEP is approved in Europe with the CE mark (in 2017) and in the USA, the Food and Drug Administration (FDA) has granted OSSURE LOEP 2020 a Breakthrough Device Designation for the treatment of stable vertebral compression fractures.

Item Type:Decision Support Document
Keywords:Osteoporosis, biomaterial, fractures, minimally invasive procedure, surgery
Subjects:W Health professions > W 100-275 Medical, dental and pharmaceutical service plans
WB Practice of medicine > WB 300-962 Therapeutics
WE Musculoskeletal system > WE 200-259 Bones
WE Musculoskeletal system > WE 800-890 Extremities and podiatry
WO Surgery > WO 500-517 Operative surgical procedures. Techniques
WO Surgery > WO 505 Minimally invasive surgical procedures
Series Name:Decision Support Document 126
Deposited on:15 Jul 2021 07:27
Last Modified:15 Jul 2021 07:27

Repository Staff Only: item control page